SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
HEPATITIS C: PROBLEMS AND PROGRESS
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
INCIDENCE OF HEPATITIS C AMONG HIV-INFECTED MEN WHO HAVE SEX WITH MEN, 2000–2015
Natasha Martin
University of California San Diego, San Diego, CA, USA
MODELING HIV-HCV EPIDEMIOLOGY IN THE DAA ERA: THE ROAD TO ERADICATION
Victor Virlogeu
INSERM, LYON, France
UNRESTRICTED DAA ACCESS IN THE NETHERLANDS: RAPID THERAPY UPTAKE IN HIV+HCV+ PATIENTS
Anne Boerekamps
Erasmus MC, Rotterdam, Netherlands
SUBSTANTIAL DECLINE IN ACUTE HCV INFECTIONS AMONG DUTCH HIV+MSM AFTER DAA ROLL OUT
Bart Rijnders
Erasmus MC Rotterdam, Rotterdam, Netherlands
CORRELATION OF RENAL BIOMARKERS AND TENOFOVIR AUC IN THE ION-4 STUDY COHORT
Austin Wei-Hong Chan
Duke University, Durham, NC, USA
HEPATOCELLULAR CARCINOMA AFTER SVR WITH IFN-FREE REGIMENS IN HIV/HCV COINFECTION
Nicolás Merchante
Hospital Universitario de Valme, Sevilla, Spain
IDENTIFICATION OF HCV INTER-SUBTYPE RECOMBINANT STRAINS WITH BREAKPOINTS IN NS5A
Suqin Cai
Monogram Biosciences, South San Francisco, USA
SYNERGY BETWEEN COMBINATIONS OF ANTI-HCV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES
Madeleine Clare Percey Mankowski
Johns Hopkins University, Severna Park, MD, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
